Literature DB >> 14274828

THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.

J R KLINENBERG, S E GOLDFINGER, J E SEEGMILLER.   

Abstract

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; DRUG THERAPY; ENZYME INHIBITORS; GOUT; METABOLISM; PURINES; PYRIMIDINES; TOXICOLOGIC REPORT; URIC ACID; URICOSURIC AGENTS; URINE; XANTHINE OXIDASE

Mesh：

Substances：

Year:  1965        PMID： 14274828     DOI： 10.7326/0003-4819-62-4-639

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  33 in total

1.  Predicting allopurinol response in patients with gout.

Authors:  Daniel F B Wright; Stephen B Duffull; Tony R Merriman; Nicola Dalbeth; Murray L Barclay; Lisa K Stamp
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

2.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

Review 3.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

4.  Uric acid metabolism in starvation.

Authors:  R H Lloyd-Mostyn; P S Lord; R Glover; C West; I C Gilliland
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

Review 5.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 6.  Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.

Authors:  Rong Fu; Chung-Jen Chen; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-05-28       Impact factor: 4.797

7.  The population pharmacokinetics of allopurinol and oxypurinol in patients with gout.

Authors:  Daniel F B Wright; Lisa K Stamp; Tony R Merriman; Murray L Barclay; Stephen B Duffull; Nicholas H G Holford
Journal:  Eur J Clin Pharmacol       Date:  2013-03-10       Impact factor: 2.953

8.  Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.

Authors:  S J Appelbaum; M Mayersohn; R T Dorr; D Perrier
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Authors:  B Breithaupt; M Tittel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 10.  A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase.

Authors:  A Kooij
Journal:  Histochem J       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.